Register
Community
Overview
Experts
Editors
Fellows
Code of conduct
Company
About Us
FAQs
Privacy Policy
Terms of Use
Careers
Programs
News
News Releases
Press Coverage
Publications
Blog
Contact Us
Sign in
Topics:
Pediatric Oncology
•
Bone Marrow Transplant
•
AML
What transplant conditioning regimen would you recommend for a pediatric patient with MDS and monosomy 7?
Related Questions
What is your current approach to maintenance therapy in FLT3-mutant AML post allogeneic HCT?
In what situations do you use G-CSF for patients undergoing allogeneic HSCT to facilitate engraftment?
How do you approach autologous stem cell transplant in T-cell lymphomas/PTCL after induction chemotherapy with achievement of CR1?
What is your approach to treating a young adult with severe aplastic anemia unresponsive to steroids and TPO-mimetics?
Do you routinely use G-CSF post-allogeneic transplant for non-haploidentical transplants?
Would you consider post-BMT maintenance therapy for patients with Ph-like ALL with a JAK2 mutation?
Do you recommend continued PCR testing in a CML patient who underwent allogeneic stem cell transplantation with an identical match about 20 years ago?
What subset of sickle cell disease patients are you offering sickle cell disease gene therapy?
Would you consider a cycle of EP in a patient with good risk stage IIIB seminoma on BEP but with bleomycin omitted for cycle 3?
How would you treat a stage IIIB recurrent seminoma with early recurrence following first-line treatment with VIP?
